No insider purchase over the last 90 days. The latest, by CONJEEVARAM SRINI, was filed 18 Aug 2015.
Derma Sciences, Inc. is a listed company. Filings by its managers are published through SEC (Form 4). Derma Sciences, Inc. has had no insider filing for more than a year; the last one goes back to 24 February 2017.
Our records for Derma Sciences, Inc. go back to 2006, with 60 purchases and 41 sales on the open market in total.
These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2015 · cache
25 of 307 declarations
Derma Sciences, Inc. is a company focused on the development of skincare products and medical devices. It is listed on NASDAQ under the symbol XNAS.